Align Technology Non-GAAP EPS of $2.80 beats by $0.04, revenue of $1.01B beats by $10M (ALGN:NASDAQ)

Align Technology reported Q3 Non-GAAP EPS of $2.80, exceeding estimates by $0.04, with revenue of $1.01B, up 1.4% Y/Y and $10M above expectations. Clear Aligner revenues rose 4.2% Y/Y to $839.3M, with volume up 6.6% to 690.6K cases.

Original reporting
Published Oct 28, 2026, 8:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALGN
Bullish
high confidence
Mentioned
$ALGN
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ALGNBullishHigh
01

Why it matters

The beat provides a fresh data point that could drive short-term buying pressure.

02

Market read

Earnings beat is a primary catalyst for the stock and may influence the dental equipment sector.

03

What to watch

Potential headwinds from supply chain constraints or competitive pricing pressure.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Align Technology released its Q3 2026 earnings, reporting a modest beat on both EPS and revenue.

Company-level read

Ticker impact

$ALGNBullishHigh confidence
Context

Q3 2026 Non-GAAP EPS of $2.80 beats consensus by $0.04 and revenue of $1.01B beats by $10M.

Expected impact

likely upside as market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded expectations, providing a fresh catalyst for buying.

Market effects

Positive earnings may lift the broader dental/orthodontic equipment sector.

U.S. market sentiment could improve in the healthcare equipment space.

Limited to U.S. investors; no immediate global macro effect.

Counterpoint

If the beat is already priced in, the stock could face short-term profit taking.

Key entities

  • Align Technology

    Provider of clear aligner orthodontic solutions.

Related articles

$ALGNMed

Align Technology Inc (ALGN) Q3 2026 Earnings Call Highlights: Record Doctor Submitters

Align Technology (ALGN) reported Q3 2026 earnings with record 91,000 doctor submitters (+3% YoY) and Clear Aligner shipments up 6.6% to 691,000. Non-GAAP operating margin was 24.4%, exceeding outlook. Revenue growth slowed to 1.9% YoY, with Systems & Services revenue down 7.6%. ASP declined 2.3% YoY. Q4 guidance was reduced due to consumer challenges and lower ASP assumptions. The company highlighted innovation in sports mouthguards and margin improvement plans for 2027.

$ALGNMedAI 8/10

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls

Align Technology (ALGN) reported Q3 2026 earnings of $2.80 per share, up 7.3% YoY, and revenues of $1.01B, up 1.9% YoY. Clear Aligner shipments increased 6.6% YoY. ALGN shares fell 0.7% post-earnings. The company lowered its 2026 revenue outlook, citing softer expectations for Systems and Services business. Q4 revenue guidance is $1.00-$1.02B, below consensus of $1.05B.